Hints and tips:
...Jeremy Levin, a member of the board and chair emeritus of Bio, a biotech industry lobby group, said an injunction would have grave consequences for women, who would struggle to access abortion care or get...
...“Seeds of financial crises are sown decades in advance,” said Jeremy Kress, a former lawyer in the banking regulation and policy group at the Fed....
...“The administration’s steps here are very unnecessary and damaging,” said Jeremy Levin, chair of biotech trade association Bio....
...“They are exactly the group you want to be helping you,” said Jeremy Levin, chair of the Biotechnology Innovation Organisation, a US trade body....
...Jeremy Levin, chair of the US biotech trade association BIO, says Mr Trump was “seemingly vindictive”, trying to harm the entire sector....
...“We went from having been a political piñata in January to a recognition, at least in the minds of many policymakers, that this is an industry that we must support,” said Jeremy Levin, chairman of the industry...
...Jeremy Levin, the chair of BIO, the biotech trade association, said the US was paying for a “troubling” lack of testing....
...Jeremy Levin, chair of BIO, the US biotech industry trade association, said it was an “absolute acute crisis”. “It's an unpreparedness challenge....
...Jeremy Levin, chair of the industry group Bio and chief executive of biotech Ovid Therapeutics, said investments had soared in rare diseases and oncology for two reasons: clinical trials were smaller and...
...Jeremy Levin, chair of the board of the Biotechnology Innovation Organisation, a US-based industry association, said the investment slowdown could hurt the ability of US biotech companies — which produce...
...He joins from Kramer Levin. Orrick has hired John Donaleski from White & Case as a partner in the law firm’s energy and infrastructure practice in New York....
...Levin, the former chief executive of Teva Pharmaceuticals....
...The letter was organised by Jeremy Levin, the former chief executive of Teva, the world’s largest generic drugmaker, who now runs a company focused on rare diseases....
...Jeremy Levin, a former Bristol-Myers executive and one of the architects of the “string of pearls” approach, says it is more sophisticated than simply doing a series of bolt-on transactions....
...Jeremy Levin, former chief executive of Teva, says that the most important factor has been financial rather than strategic....
...This marked the start of a turbulent period for Teva as it appointed its first non-Israeli chief executive — Jeremy Levin, poached from Bristol-Myers Squibb of the US — to lead a turnround....
...This was a reference to the 2013 ousting of Jeremy Levin, a former top executive at Bristol-Myers Squibb, after a clash with the board....
...Mr Vigodman will on February 11 take over from acting chief executive Eyal Desheh, who has been running the company since former CEO Jeremy Levin was sacked last year....
...“Private equity has not traditionally played in this area, so they will either have to bring in experts or partner with third parties who have the expertise,” said Jeremy Levin, former chief executive of...
...His initiative follows increasing concerns over the share price of Teva during the past two years, with worries over boardroom interference in management brought to a head with the firing of Jeremy Levin...
...Two days later, just in advance of a scheduled investor call, the directors dismissed Jeremy Levin as chief executive....
...The son of a political journalist, Mr Levin is not the only high achiever in his family – his brother, Jeremy Levin, was chief executive of Teva Pharmaceutical Industries until last October, when he was...
...Jeremy Bennett, Nomura’s European boss says tightening regulation “has the unintended consequence of excluding a large part of humanity from access to capital”....
...Mr Vigodman, an Israeli corporate veteran and Teva director, faces a challenge to stabilise management and repair investor relations after the dismissal of Jeremy Levin last October following a dispute with...
International Edition